Kapspargo SprinkleTM is the first and only FDA-approved extended-release formulation of a beta-blocker available in a sprinkle formulation with 3 administration options. Kapspargo SprinkleTM is indicated for the treatment of hypertension, angina, and heart failure.¹
Approximately 4 in 10 American adults cannot or will not swallow solid forms of medication.²
Kapspargo SprinkleTM (metoprolol succinate) requires no crushing for patients who cannot or will not swallow solid medication forms. Capsules are simply opened and their contents sprinkled over soft foods—for example, applesauce, pudding, or yogurt—or administered via nasogastric tube.¹
3 administration options that each provide the same drug release.¹
Kapspargo SprinkleTM provides the same drug release whether swallowed whole, sprinkled over soft foods, or administered via nasogastric tube.¹
Open and sprinkle over soft foods
Administer via nasogastric tube
No Need to Crush Pills—Just Open, Sprinkle, and Serve.
Metoprolol succinate formulations cannot be crushed
Patients who cannot or will not swallow solid medication forms are typically required to crush metoprolol tartrate twice a day
Kapspargo SprinkleTM offers a once-daily, extended-release metoprolol succinate with flexible administration options1
When your patients on beta-blockers cannot or will not swallow solid forms of medication, switch them to a once-daily formulation—Kapspargo SprinkleTM extended-release capsules.¹
References: 1. Kapspargo Sprinkle [prescribing information]. Cranbury, NJ: Sun Pharmaceutical Industries, Inc., 2018. 2. Center for Drug Evaluation and Research, US Food and Drug Administration. Size, Shape, and Other Physical Attributes of Generic Tablets and Capsules: Guidance for Industry. www.fda.gov/media/87344/download. Published June 2015. Accessed January 6, 2020.